Valuation Stratec SE Deutsche Boerse AG
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
03:47:11 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 24.90 EUR | +1.43% |
|
-2.23% | +8.80% |
| 08-18 | Stratec SE : Deutsche Bank is Neutral | ZD |
| 08-17 | Stratec SE : Deutsche Bank reiterates its Neutral rating | ZD |
Company Valuation: Stratec SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,669 | 983.7 | 553.7 | 362.2 | 272.9 | 296.6 | - | - |
| Change | - | -41.06% | -43.71% | -34.58% | -24.66% | 8.69% | - | - |
| Enterprise Value (EV) 1 | 1,705 | 983.7 | 520.2 | 451.5 | 385.4 | 388.8 | 392.8 | 390.8 |
| Change | - | -42.32% | -47.12% | -13.2% | -14.65% | 0.9% | 1.02% | -0.52% |
| P/E | 42x | 33.8x | 42.6x | 22.6x | -1,123x | 21.9x | 16.2x | 14.3x |
| PBR | 8.12x | - | 2.37x | 1.49x | 1.15x | 1.23x | 1.19x | 1.13x |
| PEG | - | -1.3x | -0.8x | 1x | 11x | -0x | 0.5x | 1.1x |
| Capitalization / Revenue | 5.81x | 3.58x | 2.11x | 1.41x | 1.09x | 1.13x | 1.05x | 1x |
| EV / Revenue | 5.94x | 3.58x | 1.99x | 1.75x | 1.54x | 1.48x | 1.39x | 1.32x |
| EV / EBITDA | 25.6x | 16.8x | 12.5x | 9.17x | 9.48x | 9.37x | 8.18x | 7.52x |
| EV / EBIT | 31.4x | 21.8x | 19.2x | 13.5x | 15.3x | 16x | 13.2x | 11.2x |
| EV / FCF | 39.4x | - | 46.9x | 11.6x | -23.1x | 11.5x | 21.1x | 24.6x |
| FCF Yield | 2.54% | - | 2.13% | 8.6% | -4.32% | 8.72% | 4.74% | 4.07% |
| Dividend per Share 2 | 0.952 | - | 0.55 | 0.6 | 0.6 | 0.6485 | 0.7711 | 0.8574 |
| Rate of return | 0.69% | - | 1.21% | 2.01% | 2.67% | 2.66% | 3.16% | 3.51% |
| EPS 2 | 3.28 | 2.4 | 1.07 | 1.32 | -0.02 | 1.116 | 1.505 | 1.705 |
| Distribution rate | 29% | - | 51.4% | 45.5% | -3,000% | 58.1% | 51.2% | 50.3% |
| Net sales 1 | 287.3 | 274.6 | 261.9 | 257.6 | 250.9 | 261.9 | 283.3 | 297 |
| EBITDA 1 | 66.61 | 58.58 | 41.58 | 49.21 | 40.64 | 41.5 | 48 | 51.96 |
| EBIT 1 | 54.27 | 45.05 | 27.07 | 33.46 | 25.17 | 24.29 | 29.81 | 34.78 |
| Net income 1 | 39.96 | 29.22 | 13.07 | 16.02 | -0.242 | 13.82 | 18.23 | 19.99 |
| Net Debt 1 | 36.57 | - | -33.53 | 89.25 | 112.5 | 92.22 | 96.19 | 94.15 |
| Reference price 2 | 137.80 | 81.10 | 45.55 | 29.80 | 22.45 | 24.40 | 24.40 | 24.40 |
| Nbr of stocks (in thousands) | 12,111 | 12,130 | 12,156 | 12,156 | 12,156 | 12,156 | - | - |
| Announcement Date | 3/30/22 | 3/28/23 | 3/28/24 | 5/19/25 | 4/28/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.98x | 5.3x | 20.33x | 0.31% | 223B | |
| 33.82x | 6.13x | 19.45x | 0.7% | 141B | |
| 39.06x | 10.28x | 22.68x | -.--% | 127B | |
| 16.26x | 3.34x | 10.87x | -.--% | 62.46B | |
| 19.09x | 2.3x | 11.55x | 2.67% | 49.73B | |
| 34.29x | 6.86x | 21.7x | -.--% | 50.01B | |
| 27.88x | 5.54x | 18.81x | 0.72% | 40.35B | |
| 70.32x | 6.73x | 20.5x | -.--% | 39.46B | |
| 18.81x | 5.24x | 13.54x | 1.21% | 31.41B | |
| Average | 32.17x | 5.75x | 17.71x | 0.62% | 84.97B | |
| Weighted average by Cap. | 32.16x | 6.11x | 18.95x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SBS Stock
- SBS Stock
- Valuation Stratec SE
Select your edition
All financial news and data tailored to specific country editions
